v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
SCHEDULE OF ACCOUNTS RECEIVABLE

Accounts receivable, net comprises the following categories (in thousands):

   2025   2024 
   For the year ended December 31, 
   2025   2024 
         
Product sales  $3,147   $ 
License revenues   3,000     
Total accounts receivable, net  $6,147   $ 
SCHEDULE OF NUMERATORS AND DENOMINATORS OF BASIC AND DILUTED NET INCOME (LOSS) PER SHARE AMOUNTS

A reconciliation of the numerators and the denominators of the basic and diluted net income (loss) per share computations are as follows (in thousands, except share and per share amounts):

 

   2025   2024 
   For the year ended December 31, 
   2025   2024 
         
Numerator:          
Net income (loss) used for basic net income (loss) per share  $71,183   $(63,734)
Effect of dilutive securities:          
Fair value adjustments for warrant liabilities   (4,106)    
Numerator for dilutive net income (loss) per share - net income (loss) available for common shareholders’ after the effect of dilutive securities  $67,077   $(63,734)
           
Denominator:          
Weighted average number of common shares outstanding - basic   52,952,917    41,048,206 
Effect of dilutive shares:          
Shares of common stock issuable upon exercise of stock options   176,170     
Shares of common stock underlying restricted stock   4,581,249     
Shares of common stock issuable upon exercise of warrants   7,811,234     
Shares of common stock issuable upon exercise of conversion feature of loan agreement   614,251     
Dilutive potential common shares   13,182,904     
Denominator for dilutive net income (loss) per share - adjusted weighted average shares used in computing net income (loss) per share - dilutive   66,135,821    41,048,206 
           
Earnings per share:          
Basic income (loss) per common share  $1.34   $(1.55)
Dilutive income (loss) per common share  $1.01   $(1.55)
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

 

   For the year ended December 31, 
   2025   2024 
         
Shares of common stock issuable upon exercise of stock options       176,587 
Shares of common stock underlying restricted stock       3,320,811 
Shares of common stock issuable upon exercise of conversion feature of loan agreement       614,251 
Shares of common stock issuable upon exercise of warrants   1,804,474    9,987,560 
Total   1,804,474    14,099,209